Synapse - Mark Kris

Search Within

Mark Kris

Results (26)

Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel

Journal Article

Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin

Journal Article

Krug, L. M.; Ragupathi, G.; Hood, C.; Kris, M. G.; Miller, V. A.; Allen, J. R.; Keding, S. J.; Danishefsky, S. J.; Gomez, J.; Tyson, L.; more...
Clinical Cancer Research (2004)

Fulltext@MSK | Save

Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol

Meeting Abstract

Solit, D. B.; She, Y.; Moasser, M. M.; Hudis, C. A.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
Proceedings of the American Association for Cancer Research Annual Meeting (2003)

Fulltext@MSK | Save

Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer

Meeting Abstract

Rosenzweig, K. E.; Yorke, E.; Jackson, A.; Nayak, R.; Rusch, V. W.; Kris, M. G.; Fuks, Z.; Ling, C. C.; Leibel, S. A.
International Journal of Radiation Oncology, Biology, Physics (2003)

Fulltext@MSK | Save

Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol

Meeting Abstract

Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
Clinical Cancer Research (2003)

Fulltext@MSK | Save

Phase I dose escalation study using the deep inspiration breath hold technique to safely increase dose to 81 Gy in the treatment of inoperable non-small cell lung cancer

Meeting Abstract

Rosenzweig, K. E.; Hanley, J.; Mychalczak, B.; Fuks, Z.; Mageras, G.; Yorke, E.; Ling, C. C.; Burman, C.; Ginsberg, R. J.; Kris, M. G.; more...
International Journal of Radiation Oncology, Biology, Physics (2000)

Fulltext@MSK | Save

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer

Journal Article

Rosenzweig, K. E.; Mychalczak, B.; Fuks, Z.; Hanley, J.; Burman, C.; Ling, C. C.; Armstrong, J.; Ginsberg, R.; Kris, M. G.; Raben, A.; more...
The Cancer Journal (2000)

Fulltext@MSK | Save

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

Journal Article

Armstrong, J.; Raben, A.; Zelefsky, M.; Burt, M.; Leibel, S.; Burman, C.; Kutcher, G.; Harrison, L.; Hahn, C.; Ginsberg, R.; more...
Radiotherapy and Oncology (1997)

Fulltext@MSK | Save

Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial

Journal Article

Grant, S. C.; Kostakoglu, L.; Kris, M. G.; Yeh, S. D. J.; Larson, S. M.; Finn, R. D.; Oettgen, H. F.; Cheung, N. K. V.
European Journal of Nuclear Medicine (1996)

Fulltext@MSK | Save

Comparison of phase I trials of anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (MABS) 528 and 225 labeled with I-131 and In-111

Meeting Abstract

Scott, A. M.; Baselga, J.; Divgi, C. R.; Pfister, D.; Kris, M.; Zhang, J. J.; Daghighian, F.; Carmichael, N.; Oettgen, H. F.; Larson, S. M.; more...
Journal of Nuclear Medicine (1993)

Fulltext@MSK | Save